Dianne Stoch
Direktor/Vorstandsmitglied bei GLOBEX MINING ENTERPRISES INC.
Vermögen: 1 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Dianne Stoch
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Precious Metals | 10 | |
Public Company | Precious Metals | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dianne Stoch
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Sir George Williams University | College/University | Undergraduate Degree Undergraduate Degree | |
GOLD X MINING CORP. | Precious Metals | Director/Board Member Director of Finance/CFO | |
BE RESOURCES INC. | Other Metals/Minerals | Chief Executive Officer Director of Finance/CFO | |
University of Ottawa | College/University | Undergraduate Degree Masters Business Admin | |
GOSSAN RESOURCES LIMITED | Precious Metals | Director/Board Member Director of Finance/CFO | |
Institute of Chartered Secretaries & Administrators of Canada | Corporate Officer/Principal Corporate Officer/Principal | ||
PORTEX MINERALS INC. | Other Metals/Minerals | Director/Board Member Director of Finance/CFO | |
DSA Corporate Services, Inc. | Director/Board Member Corporate Officer/Principal | ||
G2 GOLDFIELDS INC. | Precious Metals | Director of Finance/CFO Director of Finance/CFO | |
HECLA MINING COMPANY | Precious Metals | Corporate Officer/Principal | |
BLUE LAGOON RESOURCES INC. | Other Metals/Minerals | Director of Finance/CFO | |
SABRE GOLD MINES CORP. | Precious Metals | Director of Finance/CFO | |
DYNACERT INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
PTX METALS INC. | Precious Metals | Director of Finance/CFO | |
NEW FRONTIER VENTURES INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
79North Ltd.
79North Ltd. Precious MetalsNon-Energy Minerals 79North Ltd. is an exploration stage company, which engages in the acquisition, exploration and development of mineral resource properties. It holds interest in Nassau, Sela Creek and Sandpiper Gold projects. The company was founded on August 15, 2016 and is headquartered in Toronto, Canada. | Precious Metals | Director of Finance/CFO | |
SKYLIGHT HEALTH GROUP INC. | Medical/Nursing Services | Director of Finance/CFO | |
AYR WELLNESS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
REVIVAL GOLD INC. | Precious Metals | Director of Finance/CFO | |
MAGNA GOLD CORP. | Precious Metals | Director of Finance/CFO | |
SILVER STORM MINING LTD. | Precious Metals | Director of Finance/CFO | |
79NORTH INC. | Precious Metals | Director of Finance/CFO | |
STEPPE GOLD LTD. | Precious Metals | Director of Finance/CFO | |
ARANJIN RES | Other Metals/Minerals | Director of Finance/CFO | |
PHIVIDA HOLDINGS INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
Pebble Creek Mining Ltd.
Pebble Creek Mining Ltd. Precious MetalsNon-Energy Minerals Pebble Creek Mining Ltd. engages in the acquisition, exploration, development and mining of gold, copper, silver and other precious and base metals and diamonds. The company's current minerals properties are all located in India. Its mineral properties include Askot Project and Gadarwara Project. The company was founded on April 29, 1993 and is headquartered in New Westminster, Canada. | Precious Metals | Director of Finance/CFO | |
ESKAY MINING CORP. | Precious Metals | Director of Finance/CFO | |
GENSOURCE POTASH CORPORATION | Chemicals: Agricultural | Director of Finance/CFO | |
MANITOU GOLD INC. | Precious Metals | Director of Finance/CFO | |
DEVERON CORP. | Packaged Software | Director of Finance/CFO | |
REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
TINTINA MINES LIMITED | Other Metals/Minerals | Director/Board Member | |
Revive Therapeutics, Inc.
Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Pharmaceuticals: Major | Director of Finance/CFO | |
OLIVE RESOURCE CAPITAL INC. | Precious Metals | Director of Finance/CFO | |
OUTDOORPARTNER MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
MARTINA MINERALS CORP. | Precious Metals | Director of Finance/CFO | |
INVENTUS MINING CORP. | Precious Metals | Director of Finance/CFO | |
PINETREE CAPITAL LTD. | Financial Conglomerates | Director of Finance/CFO |
Statistik
International
Kanada | 48 |
Vereinigte Staaten | 3 |
Mongolei | 2 |
Sektoral
Non-Energy Minerals | 31 |
Finance | 7 |
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Operativ
Director of Finance/CFO | 98 |
Director/Board Member | 55 |
Corporate Officer/Principal | 50 |
Independent Dir/Board Member | 23 |
Corporate Secretary | 21 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Dianne Stoch
- Unternehmensverbindungen